Design and Characterization of Maltoheptaose-
Breast Neoplasms
Cell Line, Tumor
Cell Survival
/ drug effects
Chemical Phenomena
Chromatography, High Pressure Liquid
Dose-Response Relationship, Drug
Drug Carriers
/ chemistry
Drug Compounding
Drug Delivery Systems
Drug Liberation
Female
Glucans
/ chemistry
Humans
Kinetics
Models, Theoretical
Molecular Structure
Nanoparticles
/ chemistry
Particle Size
Polystyrenes
/ chemistry
Selective Estrogen Receptor Modulators
/ administration & dosage
Tamoxifen
/ administration & dosage
block copolymer
breast cancer
cytotoxicity
tamoxifen citrate
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
28 Oct 2021
28 Oct 2021
Historique:
received:
27
09
2021
revised:
24
10
2021
accepted:
26
10
2021
entrez:
13
11
2021
pubmed:
14
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Tamoxifen citrate (TMC), a non-steroidal antiestrogen drug used for the treatment of breast cancer, was loaded in a block copolymer of maltoheptaose-
Identifiants
pubmed: 34770918
pii: molecules26216507
doi: 10.3390/molecules26216507
pmc: PMC8587208
pii:
doi:
Substances chimiques
Drug Carriers
0
Glucans
0
Polystyrenes
0
Selective Estrogen Receptor Modulators
0
Tamoxifen
094ZI81Y45
maltoheptaose
3BD5BBR49M
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Council for Scientific and Technological Development
ID : 308001/2020-6
Organisme : CAPES/Print
ID : 88881.310412/2018-01
Références
Fundam Clin Pharmacol. 2021 Feb;35(1):86-96
pubmed: 32749731
Carbohydr Polym. 2015 Jun 25;124:109-16
pubmed: 25839800
Pharm Res. 2019 Jul 31;36(10):140
pubmed: 31367876
Soft Matter. 2015 Jan 7;11(1):28-32
pubmed: 25370714
Langmuir. 2013 Dec 10;29(49):15224-30
pubmed: 24256448
J Nanobiotechnology. 2021 Jan 27;19(1):32
pubmed: 33499885
Drug Discov Today. 2017 Nov;22(11):1637-1653
pubmed: 28843632
AAPS PharmSciTech. 2017 Apr;18(3):759-768
pubmed: 27287243
Carbohydr Polym. 2019 May 15;212:222-228
pubmed: 30832851
Biomacromolecules. 2015 Jul 13;16(7):2012-24
pubmed: 25974198
Beilstein J Nanotechnol. 2014 Dec 15;5:2403-12
pubmed: 25671136
J Microencapsul. 2018 May;35(3):292-300
pubmed: 29771175
Chem Soc Rev. 2017 Jun 21;46(12):3830-3852
pubmed: 28516983
J Med Chem. 2013 Jun 13;56(11):4611-8
pubmed: 23731360
Biomaterials. 2010 May;31(13):3657-66
pubmed: 20138662
J Control Release. 2006 Nov;116(1):1-27
pubmed: 17050027
Nanoscale. 2013 Apr 7;5(7):2637-41
pubmed: 23443358
Drug Dev Ind Pharm. 2020 Oct;46(10):1695-1704
pubmed: 32893676
Sci Rep. 2016 Feb 22;6:21629
pubmed: 26899926
J Control Release. 2013 May 10;167(3):276-83
pubmed: 23428841
Nanoscale Res Lett. 2010 Jul 15;5(10):1603-10
pubmed: 21076700
Chem Biodivers. 2018 Jan;15(1):
pubmed: 28834279
Int J Pharm. 2002 Dec 5;249(1-2):127-38
pubmed: 12433441
Expert Rev Clin Pharmacol. 2019 Jun;12(6):523-536
pubmed: 31008668
Breast Cancer Res Treat. 2012 May;133(1):99-109
pubmed: 21814747
Pharm Res. 2010 May;27(5):796-810
pubmed: 20204471
Nanomedicine (Lond). 2010 Feb;5(2):287-306
pubmed: 20148639
J Nanopart Res. 2013;15:2101
pubmed: 24348090
Int J Pharm. 2001 Feb 19;214(1-2):37-42
pubmed: 11282234
Chem Rev. 2016 Feb 24;116(4):2602-63
pubmed: 26854975
Pharm Res. 2013 Oct;30(10):2512-22
pubmed: 23314933
J Natl Cancer Inst. 2005 Jan 5;97(1):30-9
pubmed: 15632378
Int J Pharm. 2009 Oct 1;380(1-2):133-41
pubmed: 19635537
Pharmazie. 2010 Dec;65(12):867-70
pubmed: 21284254
Int J Pharm. 2015 Aug 1;491(1-2):99-104
pubmed: 26095916
J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75
pubmed: 15159443
Eur J Pharm Sci. 2016 Feb 15;83:88-98
pubmed: 26678154
Adv Mater. 2017 Sep;29(35):
pubmed: 28681944
Langmuir. 2016 May 10;32(18):4538-45
pubmed: 27054350
Eur J Cancer. 2002 Jan;38(1):18-22
pubmed: 11750835
Pharm Res. 1996 Dec;13(12):1838-45
pubmed: 8987081